Dejuan Zhi

Title: The Innovative Contributions of Dejuan Zhi

Introduction

Dejuan Zhi is a notable inventor based in Gansu, China. He has made significant contributions to the field of medicine through his innovative patents. With a total of two patents to his name, Zhi's work focuses on addressing critical health issues, particularly in the realm of neurodegenerative diseases.

Latest Patents

Zhi's latest patents include a fusion protein for alpha-melanocyte stimulating hormone and its preparation method and use. This fusion protein contains a protein transduction domain (PTD), human serum albumin (HSA), and alpha-melanocyte stimulating hormone (α-MSH). The invention aims to inhibit or treat central nervous system inflammations. Another significant patent involves the use of a Chinese medicine composition and Dianxianning in the preparation of a medicament for preventing or treating Alzheimer's disease. Experimental results indicate that this composition has a significant inhibiting effect on palsy phenotype in animal models of Alzheimer's disease, suggesting its potential as a preventive or therapeutic agent.

Career Highlights

Dejuan Zhi is affiliated with Lanzhou University, where he continues to engage in research and development. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Zhi collaborates with esteemed colleagues, including Hongyu Li and Yang Li, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the medical field.

Conclusion

Dejuan Zhi's contributions to medical innovation, particularly in the treatment of Alzheimer's disease and central nervous system inflammations, highlight his role as a significant inventor. His patents reflect a dedication to improving health outcomes through scientific advancement.